Peer Review reports
From: Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy
| Original Submission | ||
|---|---|---|
| 14 Nov 2022 | Submitted | Original manuscript |
| 26 Nov 2022 | Reviewed | Reviewer Report |
| 28 Nov 2022 | Reviewed | Reviewer Report - Zeyuan Wang |
| 11 Dec 2022 | Author responded | Author comments - Hui Cai |
| Resubmission - Version 2 | ||
| 11 Dec 2022 | Submitted | Manuscript version 2 |
| 21 Dec 2022 | Author responded | Author comments - Hui Cai |
| Resubmission - Version 3 | ||
| 21 Dec 2022 | Submitted | Manuscript version 3 |
| 3 Jan 2023 | Author responded | Author comments - Hui Cai |
| Resubmission - Version 4 | ||
| 3 Jan 2023 | Submitted | Manuscript version 4 |
| 11 Jan 2023 | Reviewed | Reviewer Report - Zeyuan Wang |
| 14 Jan 2023 | Reviewed | Reviewer Report |
| Resubmission - Version 5 | ||
| Submitted | Manuscript version 5 | |
| Publishing | ||
| 19 Jan 2023 | Editorially accepted | |
| 28 Feb 2023 | Article published | 10.1186/s12885-023-10564-4 |
You can find further information about peer review here.